International Journal of Heart Failure最新文献_第2页

Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment. 韩国心力衰竭学会心力衰竭治疗指南：治疗。

International Journal of Heart Failure Pub Date : 2023-04-10 eCollection Date: 2023-04-01 DOI: 10.36628/ijhf.2023.0011

Jong-Chan Youn, Darae Kim, Jae Yeong Cho, Dong-Hyuk Cho, Sang Min Park, Mi-Hyang Jung, Junho Hyun, Hyun-Jai Cho, Seong-Mi Park, Jin-Oh Choi, Wook-Jin Chung, Byung-Su Yoo, Seok-Min Kang

引用次数: 0

Pulmonary Hypertension With Unilateral Pulmonary Vein Atresia. 肺动脉高压伴单侧肺静脉闭锁。

International Journal of Heart Failure Pub Date : 2023-04-01 DOI: 10.36628/ijhf.2023.0003

Bong-Joon Kim, Soo-Jin Kim, Sung-Il Im, Hyunsu Kim, Jung-Ho Heo, Tae-Won Jang

引用次数: 0

The Mortality Benefit of Milrinone as a Continuous Outpatient Intravenous Inotrope Therapy in Advanced Heart Failure: A Systemic Review and Meta-Analysis. 米力农作为持续门诊静脉注射肌力治疗晚期心力衰竭的死亡率益处:一项系统回顾和荟萃分析。

International Journal of Heart Failure Pub Date : 2023-04-01 DOI: 10.36628/ijhf.2022.0034

Gaspar Del Rio-Pertuz, Juthipong Benjanuwattra, Phichayut Phinyo, Natnicha Leelaviwat, Poemlarp Mekraksakit, Nandini Nair

{"title":"The Mortality Benefit of Milrinone as a Continuous Outpatient Intravenous Inotrope Therapy in Advanced Heart Failure: A Systemic Review and Meta-Analysis.","authors":"Gaspar Del Rio-Pertuz, Juthipong Benjanuwattra, Phichayut Phinyo, Natnicha Leelaviwat, Poemlarp Mekraksakit, Nandini Nair","doi":"10.36628/ijhf.2022.0034","DOIUrl":"https://doi.org/10.36628/ijhf.2022.0034","url":null,"abstract":"https://e-heartfailure.org Advanced (stage D) heart failure (AHF) is defined by severe and refractory symptoms, not responding to maximum guideline-directed medical therapy, that markedly interfere with daily life and lead to recurrent hospitalizations.1) According to the AHA/ACC/ESFA 2022 guideline, continuous outpatient intravenous inotrope therapy is a strategy used as in interim treatment to those with AHF awaiting for mechanical circulatory support or cardiac transplantation (class IIa recommendation) and palliative treatment to improve symptom and functional status (class IIb recommendation).1) Milrinone and dobutamine are the most frequently used intravenous inotropes.2) Despite the aforementioned recommendation, there’s a sparsity of data comparing the benefit between those inotropic agents. Recent randomized-controlled trial and meta-analyses did not show an advantage of milrinone over dobutamine with regards to in-hospital mortality in patients with acute cardiogenic shock3-5); however, there was an increasing mortality benefit of milrinone over time, suggesting the possibility of time-dependent effect.4) A systemic review and meta-analysis was, therefore, performed to compare the mortality benefit between continuous outpatient intravenous therapy with milrinone and dobutamine.","PeriodicalId":14058,"journal":{"name":"International Journal of Heart Failure","volume":"5 2","pages":"106-110"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/30/e4/ijhf-5-106.PMC10172078.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9472972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Direct Extracorporeal Membrane Oxygenation Bridged Heart Transplantation: The Importance of Multi-Organ Failure. 直接体外膜氧合桥接心脏移植:多器官衰竭的重要性。

International Journal of Heart Failure Pub Date : 2023-04-01 DOI: 10.36628/ijhf.2023.0013

Ji Hoon Lim, Soo Yong Lee, Min Ho Ju, Seok Hyun Kim, Jin Hee Choi, Min Ku Chon, Sang Hyun Lee, Ki Won Hwang, Jeong Su Kim, Yong Hyun Park, Junehong Kim, Kook Jin Chun, Mi Hee Lim, Chee-Hoon Lee, Hyung Gon Je

{"title":"Direct Extracorporeal Membrane Oxygenation Bridged Heart Transplantation: The Importance of Multi-Organ Failure.","authors":"Ji Hoon Lim, Soo Yong Lee, Min Ho Ju, Seok Hyun Kim, Jin Hee Choi, Min Ku Chon, Sang Hyun Lee, Ki Won Hwang, Jeong Su Kim, Yong Hyun Park, Junehong Kim, Kook Jin Chun, Mi Hee Lim, Chee-Hoon Lee, Hyung Gon Je","doi":"10.36628/ijhf.2023.0013","DOIUrl":"https://doi.org/10.36628/ijhf.2023.0013","url":null,"abstract":"Background and objectives: Recently, approximately 40% of all heart transplantation (HTx) in South Korea are performed using the direct extracorporeal membrane oxygenation (ECMO) bridging method. We conducted a study to examine the clinical outcome of direct ECMO-bridged HTx and to investigate the impact of multi-organ failure (MOF).Methods: From June 2014 to September 2022, a total of 96 adult patients who underwent isolated HTx at a single tertiary hospital were included in the study. The patients were sub-grouped into ECMO (n=48) and non-ECMO group (n=48), and the ECMO group was subdivided into awake (n=22) and non-awake (n=26) groups based on mechanical ventilator (MV) dependency. Baseline characteristics, 30-day, and 1-year mortality were analyzed retrospectively.Results: The 1-year survival rate was significantly lower in the ECMO group (72.9% vs. 95.8%, p=0.002). There was a significant difference in the 30-day survival rate between the awake and non-awake ECMO groups (81.8% vs. 65.4%, p=0.032). In the univariate analysis of logistic regression for 1-year mortality, the odds ratio was 8.5 for ECMO bridged HTx compared to the non-ECMO group, 12.3 in patients who required MV (p=0.003), and 23 with additional hemodialysis (p<0.001).Conclusions: Patients who required MV in ECMO bridged HTx showed higher preoperative MOF rates and early mortality than those extubated. When considering ECMO bridged HTx, the severity of MOF should be thoroughly investigated, and careful patient selection is necessary.","PeriodicalId":14058,"journal":{"name":"International Journal of Heart Failure","volume":"5 2","pages":"91-99"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c6/de/ijhf-5-91.PMC10172075.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9461420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence. 心力衰竭中的 SGLT-2 抑制剂：当前证据综述。

International Journal of Heart Failure Pub Date : 2023-03-13 eCollection Date: 2023-04-01 DOI: 10.36628/ijhf.2022.0030

Khawaja M Talha, Stefan D Anker, Javed Butler

引用次数: 0

Evaluation and Management of Patients With Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement. 糖尿病合并心力衰竭患者的评估与管理：韩国糖尿病协会和韩国心力衰竭学会共识声明》。

International Journal of Heart Failure Pub Date : 2023-01-24 eCollection Date: 2023-01-01 DOI: 10.36628/ijhf.2022.0028

Kyu-Sun Lee, Junghyun Noh, Seong-Mi Park, Kyung Mook Choi, Seok-Min Kang, Kyu-Chang Won, Hyun-Jai Cho, Min Kyong Moon

引用次数: 0

Perirenal Fat and Renal Congestion: A Double Burden on Kidney Function in Acute Decompensated Heart Failure. 肾周脂肪和肾脏充血：急性失代偿性心力衰竭患者肾功能的双重负担。

International Journal of Heart Failure Pub Date : 2023-01-20 eCollection Date: 2023-01-01 DOI: 10.36628/ijhf.2023.0005

Dong-Hyuk Cho

引用次数: 0

Stable Severe Reduction in Ejection Fraction Following COVID-19 mRNA Vaccine: Are They Related? 注射COVID-19 mRNA疫苗后射血分数稳定严重降低:两者是否相关?

International Journal of Heart Failure Pub Date : 2023-01-01 DOI: 10.36628/ijhf.2022.0027

Bistees George, Maya Guglin

引用次数: 0

Perirenal Fat and Kidney Function Deterioration in Patients With Acute Decompensated Heart Failure. 急性失代偿性心力衰竭患者的肾周脂肪和肾功能恶化。

International Journal of Heart Failure Pub Date : 2023-01-01 DOI: 10.36628/ijhf.2022.0029

In-Jeong Cho, Jin Wi, Sang-Eun Lee, Dong-Hyeok Kim, Wook Bum Pyun

{"title":"Perirenal Fat and Kidney Function Deterioration in Patients With Acute Decompensated Heart Failure.","authors":"In-Jeong Cho, Jin Wi, Sang-Eun Lee, Dong-Hyeok Kim, Wook Bum Pyun","doi":"10.36628/ijhf.2022.0029","DOIUrl":"https://doi.org/10.36628/ijhf.2022.0029","url":null,"abstract":"Background and objectives: The thick perirenal fat pad can induce high intracapsular pressure and cause compression of the renal vasculature and resultant congestive nephropathy. The current study investigated the association of perirenal fat thickness with kidney dysfunction in patients with acute decompensated heart failure (ADHF).Methods: Data from 266 patients hospitalized with ADHF were analyzed. Patients were divided into two groups according to the glomerular filtration rate (GFR) at admission (preserved kidney function [GFR ≥60 mL/min/1.73 m2] and reduced kidney function [GFR <60 mL/min/1.73 m2] groups). Right and left posterior perirenal fat thicknesses were measured using computed tomography, and their average values were calculated. Associated factors with reduced kidney function was assessed by logistic regression model, presenting with odds ratio (OR) and confidence interval (CI).Results: Increasing age (OR, 1.08; 95% CI, 1.04-1.12; p<0.001), diabetes mellitus (OR, 2.46; 95% CI, 1.18-5.12; p<0.017), increased log N-terminal pro-B-type natriuretic peptide (NT-proBNP) (OR, 1.82; 95% CI, 1.32-2.52; p<0.001), and increased average perirenal fat thickness (OR, 1.11; 95% CI, 1.06-1.16; p<0.001) were independently associated with reduced kidney function. In the subgroup analyses, patients over 70 years old, the ratio of mitral-to-mitral annular velocity >15, elevated log NT-proBNP had a significantly higher association with increased perirenal fat thickness with reduced kidney function.Conclusions: Thick perirenal fat pads were independently associated with kidney function deterioration in patients hospitalized with ADHF.","PeriodicalId":14058,"journal":{"name":"International Journal of Heart Failure","volume":"5 1","pages":"36-47"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/53/92/ijhf-5-36.PMC9902646.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10768285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

Lifestyle Modification in Heart Failure Management: Are We Using Evidence-Based Recommendations in Real World Practice? 生活方式改变在心力衰竭管理中的作用:我们是否在现实世界的实践中使用循证建议?

International Journal of Heart Failure Pub Date : 2023-01-01 DOI: 10.36628/ijhf.2022.0032

Miguel Camafort, Seong-Mi Park, Seok-Min Kang

{"title":"Lifestyle Modification in Heart Failure Management: Are We Using Evidence-Based Recommendations in Real World Practice?","authors":"Miguel Camafort, Seong-Mi Park, Seok-Min Kang","doi":"10.36628/ijhf.2022.0032","DOIUrl":"https://doi.org/10.36628/ijhf.2022.0032","url":null,"abstract":"The heart failure (HF) guideline's purpose is to assist medical professionals while treating patients with HF in accordance with the best current research. Many cases of HF are both, avoidable and treatable thanks to scientific trials. Management is, therefore, based on lifestyle changes, also called non-pharmacological treatment. These, based on lifestyle changes, should be recommended in every patient at risk for HF or with diagnosed of HF, but evidence in itself is scarce. DASH Diet could be clearly beneficial while Mediterranean diet doesn't have enough evidence at the present moment. Smoking should be stopped, and excessive amounts of alcohol drinking avoided, but there is no clinical trial nor registry performed on these aspects. A moderate salt restriction is better than a strict reduction. Exercise and cardiac rehabilitation are beneficial but there are no clear recommendations about type, duration, etc. Most of the evidence that we have in HF patients with obesity is contradictory. Finally, due to the high number of aged frail patients in HF lifestyle changes should be individualized, but again available data is scant. Therefore, due to the lack of current evidence, these gaps need to be considered and need new efforts on investigation in the next future.","PeriodicalId":14058,"journal":{"name":"International Journal of Heart Failure","volume":"5 1","pages":"21-33"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3e/de/ijhf-5-21.PMC9902645.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10768284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3